Fingerprint
Dive into the research topics of 'A phase II study of BEZ235 in patients with everolimusresistant, advanced pancreatic neuroendocrine tumours'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II study of BEZ235 in patients with everolimusresistant, advanced pancreatic neuroendocrine tumours
Nicola Fazio, Roberto Buzzoni, Eric Baudin, Lorenzo Antonuzzo, Richard A. Hubner, Harald Lahner, Wouter W. De Herder, Markus Raderer, Alexandre Teulé, Jaume Capdevila, Steven K. Libutti, Matthew H. Kulke, Manisha Shah, Debarshi Dey, Sabine Turri, Paola Aimone, Cristian Massacesi, Chris Verslype
Research output: Contribution to journal › Article › peer-review
75
Scopus
citations